季线金叉,月线KDJ已掉头向上,大底部持续放量,从历史最低点仅上涨一倍,待利好消息逐步释放,20倍以上目标可待。查看全文
利弗魔尔2021-03-12 02:04
$Invivo治疗控股(NVIV)$ 神经脊髓支架,这个有科技含量啊,异动,估计很快有更大动作,4000万市值,目标3倍。$苹果(AAPL)$ $特斯拉(TSLA)$查看全文
chuminhua2021-03-03 16:37
3月2日,Inovio Pharmaceuticals宣布,其基于DNA的在研HPV免疫疗法VGX-3100在一项后期试验中达到了可评估受试者的主要和次要终点,可作为与人乳头瘤病毒(HPV)相关的高级别鳞状上皮内病变(HSIL)的潜在疗法。首席执行官J.Joseph Kim提出,如果获得批准,VGX-3100有可能 "成为受HPV-16-/18相...查看全文
$InVivo Therapeutics Holdings Corp.(NVIV)$ EFFECT - Notice of Effectiveness Filed: 2018-06-20 AccNo: 9999999995-18-001553 Size: 1 KB 网页链接
$InVivo Therapeutics Holdings Corp.(NVIV)$ S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)] Filed: 2018-06-20 AccNo: 0001104659-18-041380 Size: 114 KB 网页链接
$InVivo Therapeutics Holdings Corp.(NVIV)$ 8-K - Current report Filed: 2018-06-19 AccNo: 0001558370-18-005329 Size: 30 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 网页链接
$InVivo Therapeutics Holdings Corp.(NVIV)$ FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses Filed: 2018-06-14 AccNo: 0001104659-18-040190 Size: 6 MB 网页链接
$InVivo Therapeutics Holdings Corp.(NVIV)$ S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933 Filed: 2018-06-14 AccNo: 0001104659-18-040189 Size: 1 MB 网页链接
$InVivo Therapeutics Holdings Corp.(NVIV)$ 424B3 - Prospectus [Rule 424(b)(3)] Filed: 2018-06-04 AccNo: 0001558370-18-005120 Size: 913 KB 网页链接
$InVivo Therapeutics Holdings Corp.(NVIV)$ 8-K - Current report Filed: 2018-06-01 AccNo: 0001558370-18-005108 Size: 595 KBItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 5.07: Submission of Matters to a Vote of Security HoldersItem 9.01...
$InVivo Therapeutics Holdings Corp.(NVIV)$ 424B3 - Prospectus [Rule 424(b)(3)] Filed: 2018-05-17 AccNo: 0001558370-18-004857 Size: 33 KB 网页链接
$InVivo Therapeutics Holdings Corp.(NVIV)$ 8-K - Current report Filed: 2018-05-14 AccNo: 0001558370-18-004786 Size: 21 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 网页链接
$InVivo Therapeutics Holdings Corp.(NVIV)$ 424B3 - Prospectus [Rule 424(b)(3)] Filed: 2018-05-07 AccNo: 0001558370-18-004151 Size: 1 MB 网页链接